Determining whether SPN hyperexcitability arises from cell-autonomous deficits caused by the loss of FMRP, or instead represents an adaptation to extrinsic circuit disruptions, will be critical for further understanding striatal dysfunction in FXS and guiding the development of effective therapeutic strategies. This evidence concerns the gene FMR1 and fragile X syndrome.